Research programme: HIV RNase H inhibitors - Roche

Drug Profile

Research programme: HIV RNase H inhibitors - Roche

Alternative Names: R-0335; R-1206

Latest Information Update: 20 Aug 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Roche
  • Class Small molecules
  • Mechanism of Action RNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 11 Jul 2008 Discontinued - Preclinical for HIV infections in United Kingdom (PO)
  • 04 Sep 2007 Preclinical data presented at the 234th American Chemical Society National Meeting (234th-ACS-2007)
  • 01 Jun 2004 Preclinical trials in HIV infections treatment in United Kingdom (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top